Napabucasin Attenuates Resistance of Breast Cancer Cells to Tamoxifen by Reducing Stem Cell-Like Properties

Related articles

05 Aug 2020 : Clinical Research

Exosomes Mediated Transfer of Circ_UBE2D2 Enhances the Resistance of Breast Cancer to Tamoxifen by Binding to MiR-200a-3p

Ke Hu, Xianhao Liu, [...] Yi Li, Qinyang Li, Yijun Xu, Wei Zeng, Guocheng Zhong, Changhua Yu - Show fewer authors

DOI: 10.12659/MSM.922253

04 Nov 2018 : Laboratory Research

Expression of the CD59 Glycoprotein Precursor is Upregulated in an Estrogen Receptor-alpha (ER-α)-Negative and a Tamoxifen-Resistant Breast Cancer Cell Line In Vitro

Huiru Xiong, Xiaowei Jin, [...] Chuanwen You - Show fewer authors

DOI: 10.12659/MSM.910647

21 Oct 2016 : Laboratory Research

Long Non-Coding RNA (lncRNA) Urothelial Carcinoma-Associated 1 (UCA1) Enhances Tamoxifen Resistance in Breast Cancer Cells via Inhibiting mTOR Signaling Pathway

Chihua Wu, Jing Luo

DOI: 10.12659/MSM.900689

21 Feb 2015 : Clinical Research

Association of CYP2D6*10, OATP1B1 A388G, and OATP1B1 T521C Polymorphisms and Overall Survival of Breast Cancer Patients after Tamoxifen Therapy

Xuefeng Zhang, Zhichen Pu, [...] Jun Ge, Jie Shen, Xiaolong Yuan, Haitang Xie - Show fewer authors

DOI: 10.12659/MSM.893473

29 Aug 2008

The multiple applications of tamoxifen: an example pointing to SERM modulation being the aspirin of the 21st century

Maneesh N. Singh, Pierre L. Martin-Hirsch, [...] Francis L. Martin - Show fewer authors

01 Oct 2004

Long-term survival in primary breast cancer: correlation with estrogen and progesterone receptor assay results and adjuvant tamoxifen therapy

Stanisław J. Chrapusta, Jerzy Giermek, [...] Tadeusz Pieńkowski - Show fewer authors